CellWell record HH-500327
Aluminum overload in the reverse osmosis dialysis era: does it exist?
Mei-Yin Chen; Shih-Hsiang Ou; Nai-Ching Chen; Chun-Hao Yin; Chien-Liang Chen
2022
In plain language
In 99 dialysis patients tested with desferrioxamine, 47.5% showed aluminum overload despite reverse osmosis dialysis, suggesting serum aluminum should be monitored where aluminum-based phosphate binders are used.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-500327
Produced by the CellWell Research Engine, custom software owned and operated by CellWell. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.